L M Shaw Selected Research

Phosphotransferases (Kinase)

8/2001

Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L M Shaw Research Topics

Disease

11	Alzheimer Disease (Alzheimer's Disease) 08/2013 - 04/2009
8	Cognitive Dysfunction 09/2010 - 04/2009
4	Neoplasms (Cancer) 10/2015 - 04/2000
3	Breast Neoplasms (Breast Cancer) 10/2015 - 07/2001
3	Dementia (Dementias) 10/2015 - 10/2009
3	Carcinoma (Carcinomatosis) 10/2001 - 04/2001
2	Neoplasm Metastasis (Metastasis) 08/2001 - 02/2000
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2021
1	Memory Disorders (Memory Loss) 10/2015
1	Atrophy 07/2014
1	Mental Disorders (Mental Disorder) 01/2012
1	Frontotemporal Dementia (Semantic Dementia) 12/2010
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 12/2010
1	Parkinson Disease (Parkinson's Disease) 09/2010
1	Disease Progression 01/2010
1	Diarrhea 07/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2008
1	Nephrogenic Fibrosing Dermopathy 05/2008
1	Hypoxia (Hypoxemia) 08/2001
1	Kidney Diseases (Kidney Disease) 02/2001
1	Uremia 06/2000
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 04/2000
1	Renal Insufficiency (Renal Failure) 02/2000
1	Liver Diseases (Liver Disease) 02/2000
1	Colonic Neoplasms (Colon Cancer) 02/2000

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2012 - 04/2009
3	Amyloid (Amyloid Fibrils)IBA 07/2014 - 01/2012
3	Amyloid beta-PeptidesIBA 09/2010 - 04/2009
3	IntegrinsIBA 10/2001 - 04/2001
3	Pharmaceutical PreparationsIBA 02/2001 - 04/2000
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 08/2001
2	ApolipoproteinsIBA 01/2012 - 04/2009
2	Glucose (Dextrose)FDA LinkGeneric 01/2012 - 07/2010
2	Apolipoproteins E (ApoE)IBA 07/2010 - 04/2009
2	Proteins (Proteins, Gene)FDA Link 07/2010 - 08/2001
2	amyloid beta-protein (1-42)IBA 10/2009 - 04/2009
2	Tacrolimus (Prograf)FDA LinkGeneric 07/2009 - 02/2001
2	Laminin ReceptorsIBA 10/2001 - 07/2001
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2001 - 02/2000
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2015
1	Beclin-1IBA 10/2015
1	Growth Factor ReceptorsIBA 10/2015
1	Apolipoprotein E4IBA 07/2014
1	Chromogranin AIBA 07/2014
1	Cystatin CIBA 07/2014
1	Trefoil Factor-3IBA 07/2014
1	Antidepressive Agents (Antidepressants)IBA 01/2012
1	NeuropeptidesIBA 12/2010
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2010
1	ChemokinesIBA 12/2010
1	Peptides (Polypeptides)IBA 12/2010
1	Amino Acids FDA Link 10/2009
1	AD 11IBA 10/2009
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2009
1	tau Proteins (tau Protein)IBA 04/2009
1	Indicators and Reagents (Reagents)IBA 04/2009
1	Contrast MediaIBA 05/2008
1	gadodiamide (Omniscan)FDA Link 05/2008
1	GadoliniumIBA 05/2008
1	Integrin alpha6beta4IBA 08/2001
1	NeuropilinsIBA 08/2001
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2001
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2001
1	Phosphotransferases (Kinase)IBA 08/2001
1	Protein Isoforms (Isoforms)IBA 08/2001
1	SteroidsIBA 02/2001
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2001
1	AntigensIBA 02/2001
1	MacrolidesIBA 04/2000
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2000
1	Complementary DNA (cDNA)IBA 02/2000
1	Human Serum Albumin FDA LinkGeneric 02/2000
1	Cadherins (E-Cadherin)IBA 02/2000
1	Alkaline PhosphataseIBA 02/2000
1	Differentiation AntigensIBA 02/2000
1	Carcinoembryonic AntigenIBA 02/2000
1	matrigelIBA 02/2000

Therapy/Procedure

1	Tracheostomy 03/2021
1	Free Tissue Flaps 03/2021
1	Therapeutics 10/2015